MMNFQ (MedMen Enterprises) ROC %: -9.35% (As of Mar. 2023)


What is MedMen Enterprises ROC %?

MedMen Enterprises MMNFQ -90.00% ROC % is -9.35% as of Mar. 2023.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. MedMen Enterprises's annualized return on capital (ROC %) for the quarter that ended in Mar. 2023 was -9.35%.

As of today (2026-06-25), MedMen Enterprises's WACC % is 0.00%. MedMen Enterprises's ROC % is 0.00% (calculated using TTM income statement data). MedMen Enterprises earns returns that do not match up to its cost of capital. It will destroy value as it grows.


MedMen Enterprises  (OTCPK:MMNFQ) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, MedMen Enterprises's WACC % is 0.00%. MedMen Enterprises's ROC % is 0.00% (calculated using TTM income statement data). MedMen Enterprises earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


MedMen Enterprises ROC % Related Terms


MedMen Enterprises ROC % Historical Data

* Premium members only.

The historical data trend for MedMen Enterprises's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises ROC % Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -62.35 -53.20 -29.11 -13.86 -12.49

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.63 -5.08 -6.84 -8.71 -9.35

MedMen Enterprises ROC % Calculation

MedMen Enterprises's annualized Return on Capital (ROC %) for the fiscal year that ended in Jun. 2022 is calculated as:

ROC % (A: Jun. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Jun. 2021 ) + Invested Capital (A: Jun. 2022 ))/ count )
=-61.302 * ( 1 - 5.64% )/( (536.03 + 389.965)/ 2 )
=-57.8445672/462.9975
=-12.49 %

where

Invested Capital(A: Jun. 2021 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=472.464 - 107.251 - ( 14.612 - max(0, 346.659 - 175.842+14.612))
=536.03

MedMen Enterprises's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2023 is calculated as:

ROC % (Q: Mar. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2022 ) + Invested Capital (Q: Mar. 2023 ))/ count )
=-41.092 * ( 1 - 14.67% )/( (266.076 + 484.09)/ 2 )
=-35.0638036/375.083
=-9.35 %

where

Invested Capital(Q: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=238.475 - 109.832 - ( 15.605 - max(0, 237.644 - 100.211+15.605))
=266.076

Note: The Operating Income data used here is four times the quarterly (Mar. 2023) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -9.35% mean?
MedMen Enterprises (MMNFQ) has a ROC % of -9.35% as of Mar. 2023. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on MedMen Enterprises and its competitors.
Is MedMen Enterprises' ROC % too high?
MedMen Enterprises' current ROC % is -9.35%.
How does MedMen Enterprises' ROC % compare to ZTS and VTRS?
MedMen Enterprises' ROC % of -9.35% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Drug Manufacturers company?
The median ROC % among Drug Manufacturers companies is 4.44, based on 985 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on MedMen Enterprises and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedMen Enterprises's current ROC % is -9.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current ROC % of -9.35%. The current ROC % is -9.35%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current ROC % is -9.35% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMen Enterprises Business Description

Address 8740 S Sepulveda Boulevard, Suite 105, Los Angeles, CA, USA, 90045
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.